The Need for Ongoing Antimicrobial Stewardship during the COVID-19 Pandemic and Actionable Recommendations

Wei Ping Khor; Omotayo Olaoye; Nikki D'Arcy; Eva M Krockow; Rasha Abdelsalam Elshenawy; Victoria Rutter; Diane Ashiru-Oredope

doi:10.3390/antibiotics9120904

The Need for Ongoing Antimicrobial Stewardship during the COVID-19 Pandemic and Actionable Recommendations

Antibiotics (Basel). 2020 Dec 14;9(12):904. doi: 10.3390/antibiotics9120904.

Authors

Wei Ping Khor¹, Omotayo Olaoye¹, Nikki D'Arcy¹, Eva M Krockow², Rasha Abdelsalam Elshenawy³, Victoria Rutter¹, Diane Ashiru-Oredope¹

Affiliations

¹ Commonwealth Pharmacists Association, London E1W 1AW, UK.
² Department of Neuroscience, Psychology and Behaviour, University of Leicester, Leicester LE1 7RH, UK.
³ FADIC School of Antimicrobial Stewardship, Muirfield Road, Watford WD19 6LN, UK.

Abstract

The coronavirus disease (COVID-19) pandemic, which has significant impact on global health care delivery, occurs amid the ongoing global health crisis of antimicrobial resistance. Early data demonstrated that bacterial and fungal co-infection with COVID-19 remain low and indiscriminate use of antimicrobials during the pandemic may worsen antimicrobial resistance It is, therefore, essential to maintain the ongoing effort of antimicrobial stewardship activities in all sectors globally.

Keywords: COVID-19; antimicrobial stewardship; pharmacy.

Grants and funding

xx/Fleming Fund